Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NextGen and Beckpharma to collaborate in cancer treatment
The two companies have formalized their desire to collaborate in a recent letter of intent, and are presently preparing the contractual details of their collaboration. They plan to
The two companies have formalized their desire to collaborate in a recent letter of intent, and are presently preparing the contractual details of their collaboration. They plan to
According to the commission, primate use is still necessary for vital pharmaceutical research programs in areas such as immune-based diseases, neurodegenerative disorders and infectious diseases. Of the 17
The company strongly believes that many fundamental aspects of Hologic and Suros’s ATEC line of breast biopsy systems infringe Tissue Extraction Devices’s US patent. The company is seeking
Under the terms of the five-year agreement, Akorn will be responsible for the manufacturing and supply of the ophthalmic drug product that will be manufactured at the company’s
The program, facilitated through local physicians in Southern California, will remotely monitor diabetic patients through the XTend Medical Disease Management Program. The patients will be able to take
The collaboration covers Evotec’s entire drug discovery offering, including its expertise in medicinal chemistry, biology and compound sourcing. Specifically, this includes biochemical and cellular assay development and high
Under the terms of the agreement, SSI has granted Sanofi pasteur a license to its technology with regard to the use of certain fusion proteins in the development
Pharmaxis will submit its marketing authorization application following the conclusion of the ongoing safety component of the Phase III trial – an optional 12 month extension to determine
Based on the result of Qiagen’s initial research, the CMM may also provide laboratory-based genomics and proteomics services to assist Qiagen in the development and validation of new
Preliminary results reported in this grant demonstrated that specific polypeptide doxorubicin conjugates showed increased cytoxicity and decreased toxicity when used in conjunction with hyperthermia. Specific targeting of the